BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21474530)

  • 1. Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder.
    Appelbaum KL
    J Correct Health Care; 2011 Jul; 17(3):218-25. PubMed ID: 21474530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL
    J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The top ten reasons to limit prescription of controlled substances in prisons.
    Burns KA
    J Am Acad Psychiatry Law; 2009; 37(1):50-2. PubMed ID: 19297633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
    Hodgkins P; Sasané R; Meijer WM
    Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
    Cohen-Zion M; Ancoli-Israel S
    Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.
    Scott DA; Gignac M; Kronfli RN; Ocana A; Lorberg GW
    J Correct Health Care; 2016 Jan; 22(1):46-61. PubMed ID: 26672119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant treatment for children: a community perspective.
    Angold A; Erkanli A; Egger HL; Costello EJ
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adults with ADHD. An overview.
    Wender PH; Wolf LE; Wasserstein J
    Ann N Y Acad Sci; 2001 Jun; 931():1-16. PubMed ID: 11462736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder.
    Shaywitz BA; Fletcher JM; Shaywitz SE
    Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder: management.
    Szymanski ML; Zolotor A
    Am Fam Physician; 2001 Oct; 64(8):1355-62. PubMed ID: 11681777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students.
    Tuttle JP; Scheurich NE; Ranseen J
    Acad Psychiatry; 2010; 34(3):220-3. PubMed ID: 20431104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.